NBIX · Neurocrine Biosciences
AI read · Bad for NBIX
The AI's read
That removes a possible use for a medicine Neurocrine already sells for tardive dyskinesia. Some study results favored treatment, but the main test did not show a statistically reliable effect. The existing approval for tardive dyskinesia remains in place.